|
GlaxoSmithKline Pharmaceuticals Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
47664.08 Cr.
|
P/BV
|
28.50
|
Book Value (Rs.)
|
98.74
|
|
52 Week High/Low (Rs.)
|
3148/1921
|
FV/ML
|
10/1
|
P/E(X)
|
80.23
|
|
Bookclosure
|
07/11/2024
|
EPS (Rs.)
|
35.07
|
Div Yield (%)
|
1.14
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 3441.77 | 3226.38 | 3264.08 | 2895.75 | 3187.35 |
| Other Operating Revenues | 11.94 | 25.34 | 13.95 | 29.86 | 37.03 |
| Total Operating Revenues | 3453.71 | 3251.72 | 3278.03 | 2925.60 | 3224.38 |
| | | | | | |
| Other Income | 122.59 | 100.66 | 75.78 | 110.58 | 79.01 |
| Total Revenue | 3576.30 | 3352.38 | 3353.80 | 3036.18 | 3303.39 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 545.17 | 427.49 | 611.18 | 471.78 | 474.38 |
| Purchase Of Stock-In Trade | 853.08 | 788.43 | 729.44 | 823.09 | 868.92 |
| Operating And Direct Expenses | 0.00 | 73.85 | 0.00 | 0.00 | 0.00 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -63.72 | 68.96 | 15.57 | -38.02 | -35.43 |
| Employee Benefit Expenses | 624.39 | 594.99 | 610.23 | 616.16 | 628.55 |
| Finance Costs | 1.80 | 1.81 | 2.00 | 3.53 | 6.34 |
| Depreciation And Amortisation Expenses | 69.68 | 65.77 | 68.19 | 78.60 | 82.68 |
| Other Expenses | 586.10 | 493.73 | 549.73 | 454.45 | 630.71 |
| Total Expenses | 2616.50 | 2515.02 | 2586.33 | 2409.60 | 2656.15 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 959.80 | 837.37 | 767.47 | 626.59 | 647.25 |
| | | | | | |
| Exceptional Items | -143.62 | -0.97 | 11.58 | -172.60 | -341.49 |
| Profit/Loss Before Tax | 816.19 | 836.40 | 779.05 | 453.99 | 305.75 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 237.59 | 247.13 | 219.74 | 158.67 | 235.31 |
| Deferred Tax | -11.36 | -18.37 | -9.40 | 8.05 | -47.62 |
| Tax For Earlier Years | 0.00 | 0.00 | 187.94 | 0.00 | 24.86 |
| Total Tax Expenses | 226.23 | 228.76 | 398.28 | 166.72 | 212.55 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 589.96 | 607.64 | 380.77 | 287.27 | 93.20 |
| | | | | | |
| Profit/Loss From Continuing Operations | 589.96 | 607.64 | 380.77 | 287.27 | 93.20 |
| | | | | | |
| Profit/Loss From Discontinuing Operations | 0.00 | 4.13 | 1708.18 | 96.51 | 0.00 |
| Total Tax Expenses Discontinuing Operations | 0.00 | 1.08 | 394.23 | 25.63 | 0.00 |
| Net Profit/Loss From Discontinuing Operations | 0.00 | 3.04 | 1313.95 | 70.88 | 0.00 |
| Profit/Loss For The Period | 589.96 | 610.69 | 1694.72 | 358.15 | 93.20 |
| | | | | | |
| Minority Interest | 4.17 | 6.04 | 0.00 | 0.00 | 0.00 |
| Consolidated Profit/Loss After MI And Associates | 594.13 | 616.72 | 1694.72 | 358.15 | 93.20 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 41.14 | 36.08 | 99.29 | 31.35 | 5.50 |
| Diluted EPS (Rs.) | 34.83 | 36.05 | 100.04 | 21.14 | 5.50 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 542.10 | 1524.66 | 508.22 | 677.62 | 338.81 |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 69.64 |
